Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer
Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer
Not yet recruiting · NCT07707674 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Phase 1 | 2026-07-22 | NCT07707674 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Evopoint Biosciences Inc. | 12 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic Foundation | Cleveland | United States | 370 |
| Karmanos Cancer Institute | Detroit | United States | 153 |
| Oklahoma University Health Sciences Center | Oklahoma City | United States | 1 |
| SCRI at Mary Crowley | Dallas | United States | 6 |
| Scri Oncology Partners | Nashville | United States | 156 |
| START - Midwest | Grand Rapids | United States | 5 |
| START - New York Long Island | Lake Success | United States | 1 |
| START - San Antonio | San Antonio | United States | 7 |